About NeuroLeap
NeuroLeap is a Healthcare company based in Mumbai (India) founded in 2017 by Kumaar Bagrodia. Software for non-invasive brainwave assessment is provided. It operates in the Healthcare and Technology sectors. NeuroLeap has raised $46.02 thousand across 1 funding round from investors including Rajashree Birla, Sminu Jindal and Shripriya Jaipuria. NeuroLeap was last valued at $2.85 million in August 2019. Its chief executive, as recorded, is Kumaar Bagrodia. Its Indian entity Aditri Neuroscience Private Limited reported revenue of ₹84.9 Lakh. NeuroLeap offers products and services including Brain Assessment and Brain Enhancement Program. Its focus areas include HealthTech, Disease Self Management, Neurological Disorders and Monitoring.
Company details
NeuroLeap was founded in 2017 in Mumbai, India, as a provider of software focused on brain assessment within the neurotechnology sector. Non-invasive sensors are placed on the head to capture brainwaves, enabling the generation of reports on cognitive functions including attention, memory, mood, executive abilities, learning, and salience detection. Operations center on software development and data analysis for practical brain performance insights.
- Headquarters Mumbai, India
- Founders Kumaar Bagrodia
- Stage Minicorn
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website neuroleap.science
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Aditri Neuroscience Private Limited
- Date of Incorporation 08 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹84.9 Lakh
FY 2025 · -26% YoY
- Net Loss-₹15.1 Lakh
FY 2025 · -18% margin
- EBITDA-₹9.5 Lakh
FY 2025 · -11% margin
- Total Equity Funding$46.02K (USD)
in 1 rounds
- Latest Funding Round$46.02K (USD), Angel Round
Aug 2019
Associated legal entities of NeuroLeap
NeuroLeap operates through Aditri Neuroscience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aditri Neuroscience Private Limited CIN U85310MH2019PTC323794 | Active | 08 Apr 2019 | Mumbai, Maharashtra | ₹0.8 Cr | 2 | View details |
Products & Services of NeuroLeap
NeuroLeap offers a comprehensive portfolio of products and services, including Brain Assessment and Brain Enhancement Program.
Non-invasive service to evaluate subconscious brain patterns.
Sessions to improve brain functions and reduce mental health symptoms.
Apps and channels of NeuroLeap
its YouTube channel NeuroLeap has 40 subscribers and 10 videos.
Videos from NeuroLeap
The most watched videos on NeuroLeap's YouTube channel, NeuroLeap (40 subscribers). Click a video to play it here.
More on NeuroLeap.
Funding Insights of NeuroLeap
NeuroLeap has successfully raised a total of $46.02K through 1 strategic funding round. The most recent funding activity was a Angel Round of $46.02 thousand completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $46,022
- Total Rounds 1
- Last Round Angel Round — $46,022
- First Round $46,022
(Aug 2019)
- Investors Count 3
All 1 funding rounds of NeuroLeap with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | $46,022 | Angel Round | $2.85M | Rajashree Birla, Sminu Jindal |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2019 | $2.85M | •••••••• |
Last known valuation $2.85M (Aug 2019). 3 investors in total: 0 institutional and 3 angel.
Investors in NeuroLeap
NeuroLeap has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Rajashree Birla, Sminu Jindal and Shripriya Jaipuria.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
RB Rajashree Birla | unknown_4959bd2811f848f39 | |||
SJ Sminu Jindal | unknown_26042b62272645659 | |||
SJ Shripriya Jaipuria | unknown_fb8342de235c4364a |
Investor details for NeuroLeap
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aditri Neuroscience Private Limited (NeuroLeap)
Aditri Neuroscience Private Limited is the primary company behind NeuroLeap. The board of Aditri Neuroscience Private Limited currently have 2 directors; the longest-serving is Kumaar Bagrodia, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kumaar Bagrodia DIN 00246736 | Director | 08 Apr 2019 | 7 yrs 6 mo | Aditri Neuroscience Private Limited |
| Rituu Kumar Bagrodia DIN 05265741 | Director | 08 Apr 2019 | 7 yrs 6 mo | Aditri Neuroscience Private Limited |
People of NeuroLeap
1 people are tracked at NeuroLeap (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for NeuroLeap
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of NeuroLeap
Figures of Aditri Neuroscience Private Limited, the primary company behind NeuroLeap, for FY 2025. Revenue was ₹84.9 Lakh (-26% year on year). Net loss was -₹15.1 Lakh (-18% margin). EBITDA was -₹9.5 Lakh (-11% margin). Revenue has grown at a compounded annual rate of +6% over three years and +3% over five years.
- ₹84.9 LakhRevenue · FY 2025 · -26% YoY
- -₹15.1 LakhNet loss · -18% margin
- -₹9.5 LakhEBITDA · -11% margin
- ₹31 LakhPaid-up capital
- +6%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aditri Neuroscience Private Limited are on its company page.
Detailed financial statements for NeuroLeap
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NeuroLeap
3 dated milestones of NeuroLeap across 2 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroLeap is founded.
- Funding First funding round of $46K.
- Milestone Reaches Minicorn status.
Web traffic of NeuroLeap
The website of NeuroLeap (neuroleap.science) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 31.1% vs previous month
Websites whose visitors overlap most with NeuroLeap. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nexstem.ai | 100% | 6.3K | #3,442,358 | View details |
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as NeuroLeap (Health Monitoring & Wearables) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
AI-powered EMR, EHR, and patient engagement solutions are provided. | 2020 | Bengaluru, Karnataka, India | USD 19.5 M | USD 3.36 M | 117 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuroleap
Complete news archive for NeuroLeap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroLeap
NeuroLeap was founded in 2017 and raised its 1st funding round 2 years after it was founded.
NeuroLeap is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Kumaar Bagrodia is the CEO of NeuroLeap, as recorded in our data. They have also founded this company.
NeuroLeap is a funded company, having raised a total of $46.02K across 1 funding round to date. The company's 1st funding round was a Angel Round of $46.02K, raised on Aug 2019.
The primary company behind NeuroLeap, Aditri Neuroscience Private Limited, reported revenue of ₹84.9 Lakh for FY 2025, down 26% year on year.
NeuroLeap was founded in 2017 in Mumbai, India, as a provider of software focused on brain assessment within the neurotechnology sector. Non-invasive sensors are placed on the head to capture brainwaves, enabling the generation of reports on cognitive functions including attention, memory, mood, executive abilities, learning, and salience detection. Operations center on software development and data analysis for practical brain performance insights.
NeuroLeap offers Brain Assessment and Brain Enhancement Program.
NeuroLeap has 3 investors. Key investors include Rajashree Birla, Sminu Jindal, and Shripriya Jaipuria.
The valuation of NeuroLeap is $2.85M as of Aug 2019.
NeuroLeap operates through Aditri Neuroscience Private Limited.
The legal entities of NeuroLeap currently have 2 directors, including Kumaar Bagrodia, Rituu Kumar Bagrodia.